{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:09:15Z","timestamp":1771654155046,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Polish National Scientific Centre, Poland","award":["DEC-2013\/11\/B\/NZ7\/02081"],"award-info":[{"award-number":["DEC-2013\/11\/B\/NZ7\/02081"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejmech.2015.07.017","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T20:04:27Z","timestamp":1436817867000},"page":"14-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Design, synthesis and biological activity of new amides derived from 3-methyl-3-phenyl-2,5-dioxo-pyrrolidin-1-yl-acetic acid"],"prefix":"10.1016","volume":"102","author":[{"given":"Jolanta","family":"Obniska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Rapacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Rybka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Powro\u017anik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"P\u0119kala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Filipek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"\u017bmudzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Kami\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.07.017_bib1","series-title":"The Phamacological Basis of Therapeutics","first-page":"583","author":"McNamara","year":"2011"},{"key":"10.1016\/j.ejmech.2015.07.017_bib2","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1528-1167.2008.01579.x","article-title":"The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country","volume":"49","author":"Picot","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejmech.2015.07.017_bib3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1586\/ern.10.71","article-title":"Adverse effects of antiepileptic drugs: a brief overview of important issues","volume":"10","author":"Cramer","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejmech.2015.07.017_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0166-1280(00)00364-X","article-title":"Pharmacophore searching and QSAR analysis in the design of anticonvulsant drugs","volume":"504","author":"Tasso Bruno-Blanch","year":"2000","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2015.07.017_bib5","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/S0960-894X(03)00535-3","article-title":"Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity","volume":"13","author":"Bruno-Blanch","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.07.017_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2006.10.008","article-title":"Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)","volume":"73","author":"Bialer","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejmech.2015.07.017_bib7","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ejmech.2008.05.020","article-title":"Synthesis and anticonvulsant activity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 3-phenyl-pyrrolidine-2,5-dione","volume":"44","author":"Obniska","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.017_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ardp.200500219","article-title":"Synthesis, physicochemical and anticonvulsant properties of new N-(pyridine-2-yl) derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione. Part II","volume":"339","author":"Kami\u0144ski","year":"2006","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2015.07.017_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ardp.201400152","article-title":"Synthesis physicochemical and anticonvulsant properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and its 3-methyl analog","volume":"347","author":"Rybka","year":"2014","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2015.07.017_bib10","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1016\/j.bmc.2010.06.064","article-title":"Design, synthesis, and anticonvulsant activity of new N-Mannich bases derived from spirosuccinimides and spirohydantoin","volume":"18","author":"Obniska","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.017_bib11","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.bmc.2012.05.032","article-title":"Synthesis and anticonvulsant activity of new N-Mannich bases derived from 3-(2-fluorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-diones. Part II","volume":"20","author":"Obniska","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.017_bib12","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1016\/j.bmc.2015.03.038","article-title":"Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives","volume":"23","author":"Kami\u0144ski","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.017_bib13","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1016\/j.ejmech.2011.07.043","article-title":"Synthesis and anticonvulsant properties of new acetamide derivatives of phthalimide, and its saturated cyclohexane and norbornene analogs","volume":"46","author":"Kami\u0144ski","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.017_bib14","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1016\/j.bmcl.2011.07.118","article-title":"Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones","volume":"21","author":"Kami\u0144ski","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.07.017_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejmech.2013.05.011","article-title":"Synthesis and biological properties of new N-Mannich bases derived from 3-methyl-3-phenyl- and 3,3-dimethyl-succinimides. Part V","volume":"66","author":"Kami\u0144ski","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.017_bib16","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.bmc.2012.04.002","article-title":"Synthesis, anticonvulsant activity, and neuropathic pain-attenuating activity of N-benzyl 2-amino-2-(hetero)aromatic acetamides","volume":"20","author":"Baruah","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.017_bib17","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1021\/jm200759t","volume":"54","author":"King","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.017_bib18","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1021\/jm2004305","article-title":"Primary amino acid derivatives: compounds with anticonvulsant and neuropathic pain protection activities","volume":"54","author":"King","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.017_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0027-5107(00)00114-7","article-title":"Practical aspects of mutagenicity testing strategy: an industrial perspective","volume":"55","author":"Gollapudi","year":"2000","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2015.07.017_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mrgentox.2013.07.011","article-title":"Evaluation of mutagenic and antimutagenic properties of new derivatives of pyrrolidine-2,5-dione with anti-epileptic activity, by use of the Vibrio harveyi mutagenicity test","volume":"758","author":"P\u0119kala","year":"2013","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2015.07.017_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3998\/ark.5550190.0004.502","article-title":"Synthesis of 3,3-diarylpyrrolidines from diaryl ketones","volume":"5","author":"Katritzky","year":"2003","journal-title":"ARKIVOC"},{"key":"10.1016\/j.ejmech.2015.07.017_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","volume":"20","author":"L\u00f6scher","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.ejmech.2015.07.017_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.eplepsyres.2005.09.012","article-title":"Molecular targets versus models for new antiepileptic drug discovery","volume":"68","author":"Rogawski","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejmech.2015.07.017_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6\u00a0Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejmech.2015.07.017_bib25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2015.07.017_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nurt.2006.11.010","article-title":"Molecular targets for antiepileptic drug development","volume":"4","author":"Meldrum","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2015.07.017_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0028-3908(02)00400-8","article-title":"Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels","volume":"44","author":"Liu","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2015.07.017_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.09.005","article-title":"Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX)","volume":"83","author":"Bialer","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejmech.2015.07.017_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1383-5718(02)00112-2","article-title":"Comparison of the Ames test and a newly developed assay for detection of mutagenic pollution of marine environments","volume":"519","author":"Czy\u017c","year":"2002","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2015.07.017_bib30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1528-1157.1978.tb04507.x","article-title":"Antiepileptic drug development: II. Anticonvulsant drug screening","volume":"19","author":"Krall","year":"1978","journal-title":"Epilepsia"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ejmech.2015.07.017_bib31","first-page":"64","article-title":"Antiepileptic drug development program: a cooperative effort of government and industry","volume":"30","author":"Kupferberg","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejmech.2015.07.017_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-3565(25)05160-2","article-title":"Comparative assay of an antiepileptic drugs by psychomotor seizure test and minimal electroshock threshold test","volume":"107","author":"Brown","year":"1953","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2015.07.017_bib33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.0013-9580.2004.04504.x","article-title":"Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice","volume":"45","author":"Kaminski","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejmech.2015.07.017_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A\u00a0simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2015.07.017_bib35","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1124\/jpet.302.3.1168","article-title":"Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception","volume":"302","author":"Laughlin","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2015.07.017_bib36","first-page":"81","article-title":"Une nouvelle m\u00e9thode simple pour explorer l'action tranquilisante: le test de la chemin\u00e9e","volume":"3","author":"Boissier","year":"1960","journal-title":"Med. Exp."},{"key":"10.1016\/j.ejmech.2015.07.017_bib37","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1523\/JNEUROSCI.06-07-02064.1986","article-title":"3H-batrachotoxinin-A benzoate binding to voltage-sensitive sodium channels: inhibition by the channel blockers tetrodotoxin and saxitoxin","volume":"6","author":"Brown","year":"1986","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2015.07.017_bib38","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1523\/JNEUROSCI.08-09-03354.1988","article-title":"Omega-conotoxin GVIA binding to a high-affinity receptor in brain: characterization, calcium sensitivity, and solubilization","volume":"8","author":"Wagner","year":"1988","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2015.07.017_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-1161(83)90010-9","article-title":"Revised methods for the Salmonella mutagenicity test","volume":"113","author":"Maron","year":"1983","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2015.07.017_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/AEM.66.2.599-605.2000","article-title":"Genetically modified Vibrio harveyi strains as potential bioindicators of mutagenic pollution of marine environments","volume":"66","author":"Czy\u017c","year":"2000","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ejmech.2015.07.017_bib41","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/ptr.3059","article-title":"Mutagenic and antimutagenic effects of hexane extract of some Astragalus species grown in the eastern Anatolia region of Turkey","volume":"24","author":"Gulluce","year":"2010","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejmech.2015.07.017_bib42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0027-5107(00)00064-6","article-title":"The Ames Salmonella\/microsome mutagenicity assay","volume":"45","author":"Mortelmans","year":"2000","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2015.07.017_bib43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1472-765X.2009.02781.x","article-title":"Evaluation of mutagenic and antimutagenic properties of some bioactive xanthone derivatives using Vibrio harveyi test","volume":"50","author":"S\u0142oczy\u0144ska","year":"2010","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2015.07.017_bib44","series-title":"Discovery and Preclinical Development of Antiepileptic Drugs in Antiepileptic Drugs","first-page":"43","author":"White","year":"2002"},{"key":"10.1016\/j.ejmech.2015.07.017_bib45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1126\/science.10636771","article-title":"Bacterial bioluminescence: isolation and expression of the luciferase genes from Vibrio harveyi","volume":"218","author":"Belas","year":"1982","journal-title":"Science"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415301495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415301495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:49:56Z","timestamp":1748494196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415301495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":45,"alternative-id":["S0223523415301495"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.07.017","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological activity of new amides derived from 3-methyl-3-phenyl-2,5-dioxo-pyrrolidin-1-yl-acetic acid","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}